FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 76630

Price move▼ Bearish

SPDR Biotech ETF -1.5%

KINDPrice move
DIRECTION▼ Bearish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Biotech weakness suggests risk appetite fading in rate-sensitive small-cap healthcare.

Biotech sensitive to rate and risk sentiment
CATALYST TO WATCH

FDA decisions and clinical trial data

MAIN RISK

M&A news could lift the sector

FULL DISPATCH

SPDR Biotech ETF (XBI) moved -1.5% in the latest period (1d). Close: 151.40, prior: 153.77.

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01yfinancefinance.yahoo.com · PRIMARY2026-10-13 00:36 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
2026-10-13 00:50 UTC
→CORRELATIONshares Healthcare
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged
2026-10-12 20:10 UTC
←CORRELATIONshares Healthcare, XBI
RNAi Drug Startup City Therapeutics Files for IPO
2026-10-12 14:31 UTC
←CORRELATIONshares Healthcare, XBI
Gottlieb on how AI is assisting in the development of cancer vaccines
2026-10-12 19:00 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.